{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:33:11Z","timestamp":1786116791005,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prro.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:32:07Z","timestamp":1786019527000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bullous Pemphigoid Induced by Whole Breast Radiation in the Setting of Concurrent Pembrolizumab: A Case Report and Review of the Literature"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-3678","authenticated-orcid":false,"given":"Brody","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remington","family":"Bristol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2026.06.003_bib0009","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.06.003_bib0001","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/ijd.13984","article-title":"A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors","volume":"57","author":"Lopez","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.prro.2026.06.003_bib0002","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti\u2013PD-1 and anti\u2013PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2026.06.003_bib0003","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaad.2018.07.008","article-title":"Bullous disorders associated with anti\u2013PD-1 and anti\u2013PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy","volume":"79","author":"Siegel","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.prro.2026.06.003_bib0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejca.2016.02.010","article-title":"Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor","volume":"60","author":"Belum","year":"2016","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.prro.2026.06.003_bib0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jdcr.2019.02.008","article-title":"Pembrolizumab-induced bullous pemphigoid","volume":"5","author":"Sun","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.prro.2026.06.003_bib0006","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamadermatol.2022.1624","article-title":"Association of bullous pemphigoid with immune checkpoint inhibitor therapy in patients with cancer: A systematic review","volume":"158","author":"Asdourian","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.prro.2026.06.003_bib0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2006.11.014","article-title":"Radiation-induced bullous pemphigoid: A systematic review of an unusual radiation side effect","volume":"82","author":"Mul","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.06.003_bib0008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000362208","article-title":"Relationship between radiation therapy and bullous pemphigoid","volume":"229","author":"Nguyen","year":"2014","journal-title":"Dermatology"},{"issue":"20","key":"10.1016\/j.prro.2026.06.003_bib0010","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.3390\/ijms222011061","article-title":"The abscopal effect: a review of pre-clinical and clinical advances","volume":"22","author":"Janopaul-Naylor","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.prro.2026.06.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028199","article-title":"Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: a case report of abscopal toxicities","volume":"100","author":"Huynh","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.prro.2026.06.003_bib0012","unstructured":"National Comprehensive Care Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Management of Immunotherapy-Related Toxicities. Version 1.2026. Accessed March 20, 2026. https:\/\/www.nccn.org"},{"key":"10.1016\/j.prro.2026.06.003_bib0013","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026001967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026001967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:32:10Z","timestamp":1786019530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"alternative-id":["S1879850026001967"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.003","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bullous Pemphigoid Induced by Whole Breast Radiation in the Setting of Concurrent Pembrolizumab: A Case Report and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}